VERVE THERAPEUTICS INC. - COMMON STOCK

Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results

05 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

01 Nov 2024 16:26:49 By Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

02 Oct 2024 16:05:00 By Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 Sep 2024 16:05:00 By Nasdaq GlobeNewswire

Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results

08 Aug 2024 07:00:01 By Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

02 Aug 2024 16:05:00 By Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

01 Jul 2024 16:05:00 By Nasdaq GlobeNewswire

Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Directors

28 Jun 2024 07:00:00 By Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

31 May 2024 16:01:00 By Nasdaq GlobeNewswire

Verve Therapeutics Announces Leadership Update

31 May 2024 07:00:00 By Nasdaq GlobeNewswire

Verve Therapeutics to Participate in Upcoming Investor Conferences

30 May 2024 16:01:00 By Nasdaq GlobeNewswire

Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results

08 May 2024 07:00:01 By Nasdaq GlobeNewswire

Verve Therapeutics Announces Dosing of First Patient in Heart-2 Phase 1b Clinical Trial Evaluating VERVE-102

07 May 2024 07:00:00 By Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 May 2024 16:01:00 By Nasdaq GlobeNewswire

Verve Therapeutics Announces Updates on its PCSK9 Program

02 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

28 Mar 2024 16:51:34 By Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

01 Mar 2024 16:01:00 By Nasdaq GlobeNewswire

Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results

27 Feb 2024 07:30:00 By Nasdaq GlobeNewswire

Verve Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

01 Feb 2024 06:30:00 By Nasdaq GlobeNewswire

Verve Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

02 Jan 2024 06:30:11 By Nasdaq GlobeNewswire